Answers are grounded in this paper and cite their sources.
The remarkably impaired absolute counts of the CD3⁺, CD4⁺, CD8⁺, B, and NK cells in patients with breast cancer can be used as potential susceptible biomarkers to evaluate the patient's immune status. The higher level of CD4⁺ and CD8⁺ absolute counts probably contributed to the longer PFS and favorable outcome of BC patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: